Report overview
Inhalational anaesthesia drugs, ether and halothane were more commonly used in the past, and sevoflurane, desflurane, and isoflurane are more commonly used. Inhaled anesthetics can enter the lungs through the patient's respiratory tract, diffuse into the capillaries, and then enter the body's circulatory system and central nervous system. For inhalational anaesthesia drugs, professional equipment should be used. The patient can make the pain and consciousness disappear within a few minutes after the inhalation anesthesia, so that the operation can proceed smoothly. After stopping the medication, the patient can quickly regain self-awareness. Inhaled anesthetics are characterized by strong controllability and high safety, and they are a common method of anesthesia used in clinical practice.
This report aims to provide a comprehensive presentation of the global market for Inhalational Anaesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalational Anaesthesia Drugs. This report contains market size and forecasts of Inhalational Anaesthesia Drugs in global, including the following market information:
Global Inhalational Anaesthesia Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Inhalational Anaesthesia Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Enflurane Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Inhalational Anaesthesia Drugs include AbbVie Inc., Baxter, Hikma Pharmaceuticals PLC, Halocarbon Products Corporation, Piramal Enterprises Limited and Lunan Pharmaceutical Group Co. Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inhalational Anaesthesia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhalational Anaesthesia Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Inhalational Anaesthesia Drugs Market Segment Percentages, by Type, 2022 (%)
Enflurane
Isoflurane
Halothane
Sevoflurane
Atropine
Global Inhalational Anaesthesia Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Inhalational Anaesthesia Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Inhalational Anaesthesia Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Inhalational Anaesthesia Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inhalational Anaesthesia Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Inhalational Anaesthesia Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc.
Baxter
Hikma Pharmaceuticals PLC
Halocarbon Products Corporation
Piramal Enterprises Limited
Lunan Pharmaceutical Group Co. Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inhalational Anaesthesia Drugs, market overview.
Chapter 2: Global Inhalational Anaesthesia Drugs market size in revenue.
Chapter 3: Detailed analysis of Inhalational Anaesthesia Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inhalational Anaesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
